PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Diphtheria Antitoxin→

Diphtheria Antitoxin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
Not available
Molecular formula
Not available
Molecular weight
~150000 g/mol
Drug class
Equine-derived polyclonal antitoxin immunoglobulintoxin-neutralising biologic
Mechanism of action
Contains antibodies that bind and neutralise circulating diphtheria toxin, preventing toxin from entering cells and inhibiting further tissue injury. It does not reverse toxin already internalised into cells.
Indications / reported uses
  • Treatment of suspected or confirmed respiratory diphtheria as early as possible, together with appropriate antibiotics and supportive care; administration requires urgent public-health and specialist guidance

Sources: CDC — Clinical guidance for diphtheria · WHO — Diphtheria antitoxin clinical guidance · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Diphtheria Antitoxin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Diphtheria Antitoxin Permitted Daily Exposure (PDE) report (the Diphtheria Antitoxin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Diphtheria Antitoxin Occupational Exposure Limit (OEL) report (the Diphtheria Antitoxin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.